Mercer Global Advisors
RNTX

Mercer Global Advisors’s Rein Therapeutics RNTX Stock Holding History

Mercer Global Advisors’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5K Buy
50,461
+15,000
+42% +$18.1K ﹤0.01% 3514
2026
Q1 		$46.1K Buy
35,461
+17,500
+97% +$21.7K ﹤0.01% 3128
2025
Q4 		$20.8K Buy
17,961
+7,500
+72% +$10.3K ﹤0.01% 2822
2025
Q3 		$12K Buy
+10,461
New +$13.3K ﹤0.01% 2628
2022
Q4 		– Sell
-1,005
Closed -$4K – 2005
2022
Q3 		$4K Hold
1,005
– – ﹤0.01% 1816
2022
Q2 		$5K Hold
1,005
– – ﹤0.01% 1816
2022
Q1 		$10K Sell
1,005
-100
-9% -$905 ﹤0.01% 1865
2021
Q4 		$12K Buy
1,105
+55
+5% +$851 ﹤0.01% 1794
2021
Q3 		$21K Hold
1,050
– – ﹤0.01% 1744
2021
Q2 		$26K Buy
1,050
+2
+0.2% +$50 ﹤0.01% 1658
2021
Q1 		$30K Buy
1,048
+348
+50% +$11.9K ﹤0.01% 1598
2020
Q4 		$15K Buy
+700
New +$17.5K ﹤0.01% 1342

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Mercer Global Advisors's RNTX Position: Q2 2026 in Review

Mercer Global Advisors increased its Rein Therapeutics (RNTX) stake by 42% in Q2 2026, buying an estimated $18.1K and bringing the position to 50,461 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

Mercer Global Advisors first reported a position in RNTX in Q4 2020 and has held it in 12 quarters since. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Mercer Global Advisors held 50,461 shares of Rein Therapeutics worth $52.5K as of Q2 2026.
  • Mercer Global Advisors bought 15,000 Rein Therapeutics shares in Q2 2026, an estimated $18.1K.
  • Rein Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3514 holding.
  • Mercer Global Advisors first reported a position in Rein Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.